(Q47819031)

5 February 2018

review article

1 reference

title

Psychoneuroendocrinology of depression. Growth hormone (English)

1 reference

5 February 2018

author

Timothy G. Dinan

series ordinal

1

1 reference

5 February 2018

publication date

1 June 1998

1 reference

5 February 2018

Psychiatric Clinics of North America

published in

1 reference

5 February 2018

volume

21

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

325-339

1 reference

5 February 2018

Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Neuroendocrine evaluation of catecholaminergic neurotransmission in mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Alpha-2 adrenergic receptor function in post-stroke depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Neuroendocrine challenge tests in depression: a study of growth hormone, TRH and cortisol release

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Somatomedin-C Mediates Growth Hormone Negative Feedback by Effects on Both the Hypothalamus and the Pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Insulin-induced hypoglycaemic response and release of growth hormone in depressed patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Neuroendocrine and amine studies in affective illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Presynaptic alpha 2 -adrenergic stimulation leads to growth hormone release in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Neuroendocrine responses to intravenous tryptophan in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Pathophysiology of "cholinoceptor supersensitivity" in affective disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Glucocorticoids and the genesis of depressive illness. A psychobiological model

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Responses of growth hormone to desipramine in endogenous and non-endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Assessment of central noradrenergic functioning in irritable bowel syndrome using a neuroendocrine challenge test

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Lowering Cortisol enhances growth hormone response to growth hormone releasing hormone in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Circadian variation of basal plasma growth hormone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Another view of GH neuroregulation: lessons from the sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone responses to the alpha 2-adrenoceptor agonist guanfacine and to growth hormone releasing hormone in depressed patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone neurosecretory disfunction in major depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Somatostatin impairs sleep in elderly human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone response to growth hormone-releasing hormone and clonidine in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Psychiatric sequelae of chronic exposure to organophosphorus insecticides

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effects of alpha- and Beta-adrenergic agonists and antagonists on growth hormone secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone-releasing peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

The cholinergic rapid eye movement induction test with arecoline in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Clonidine-induced increase in serum growth hormone: Possible role of epinephrine-mediated synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

GABA levels in CSF of patients with psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

A cholinergic-adrenergic hypothesis of mania and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Galanin receptors: involvement in feeding, pain, depression and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effects of neonatal treatment with monosodium glutamate on growth hormone release induced by clonidine and prostaglandin E1 in conscious male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone-releasing factor stimulation test in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitaryin Vitro1

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effect of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--I. Growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Apomorphine in the evaluation of dopaminergic function in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effects of growth hormone-releasing factor and somatostatin on growth hormone secretion and cellular cyclic AMP levels. Cultured ovine and rat anterior pituitary cells show markedly different responses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effect of enhancement of endogenous cholinergic tone with pyridostigmine on growth hormone (GH) responses to GH-releasing hormone in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone (GH) response to GH-releasing hormone in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Abnormal responsiveness of growth hormone to human corticotropin-releasing hormone in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Reduction of GH response to the GABA-B agonist baclofen in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Neural regulation of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effect of clonidine on growth hormone release in psychiatric patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Occurrence of galanin-like immunoreactivity in growth hormone-releasing factor (GRF)-containing neurons of the monkey (Macaca fascicularis) infundibular nucleus and median eminence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Diurnal hypersecretion of growth hormone in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effects of intracerebroventricular administration of growth hormone-releasing factor and corticotropin-releasing factor on somatostatin secretion into rat hypophysial portal blood

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Multihormonal responses to apomorphine in mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Neural control of somatotropic function

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Increased hypothalamic somatostatin mRNA following dexamethasone administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Antiserum to growth hormone decreases sleep in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Baclofen-induced growth hormone release in major depression: relationship to dexamethasone suppression test result

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effect of fluoxetine on noradrenergic mediated growth hormone release: A double blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Cholinergic and adrenergic function in depressed and healthy subjects: A neuroendocrine test battery using the growth hormone axis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Pyridostigmine-induced growth hormone responses in healthy and depressed subjects: evidence for cholinergic supersensitivity in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Relationship between alpha2-adrenergic function and suicidal behavior in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

1 reference

7 January 2021

Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

CSF GABA in depressed patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone and prolactin in unipolar and bipolar depressed patients: responses to hypoglycemia and L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

A review of GHRH stimulation test in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Effect of fluoxetine on dexamethasone-induced growth hormone release in depression: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Growth hormone secretion: the role of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Subnormal growth hormone responses to acutely administered dexamethasone in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

GH responses to growth hormone releasing factor in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

Blunted growth hormone response to clonidine in panic disorder patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970008-3

7 January 2021

10.1016/S0193-953X(05)70008-3

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018